Home / Transcripts / Halma plc (HLMA) · June 11, 2026

Halma plc (HLMA) Earnings Call Transcript & Summary

June 11, 2026

London Stock Exchange GB Information Technology Electronic Equipment, Instruments and Components earnings 73 min

What were the key takeaways from Halma plc's June 11, 2026 earnings call?

Halma plc reported strong full-year results for FY '26, achieving a record performance with organic revenue growth of 16% and EBIT growth of 19%. The company maintained its 23rd consecutive year of profit growth, driven by broad-based contributions across all sectors, particularly from its Photonics business which saw a remarkable growth rate of 52%. Management has guided for low double-digit organic revenue growth for FY '27, including a projected 5 percentage points from the Photonics segment, indicating continued confidence in their sustainable growth model despite macroeconomic uncertainties.

What topics did Halma plc cover?

What were Halma plc's June 11, 2026 results?

Halma's robust performance in FY '26 reinforces its sustainable growth model, driven by strong sector contributions and strategic investments. The guidance for FY '27 suggests continued growth, albeit at a moderated pace, with key areas to monitor including the Photonics segment's scaling capabilities and margin management amidst reinvestment strategies. Investors should watch for M&A activity and the company's ability to navigate macroeconomic challenges.

Earnings Call Speaker Segments

Marc Ronchetti executive
#1

Good morning, everyone, and welcome to the presentation of our full year '26 results. It's a pleasure to be here presenting such a strong set of results for the year — results that yet again show the quality of our businesses and the strength of our sustainable growth model, one built over decades of disciplined choices about which markets we operate in, which companies we acquire, and which leaders we trust to run them. I want to begin today by thanking everybody at Halma for their individual contributions to our record performance, something we should all be incredibly proud of. Together, we keep making a meaningful difference by pursuing our purpose of growing a safer, cleaner, healthier future for everyone, every day. Carole will give you more insight into our financial performance shortly, but let me first start with the highlights. It's fantastic to report our 23rd consecutive year of profit growth, and I'm really pleased to see these results underpinned by strong, broad-based organic growth delivered across all three sectors. Our results include a premium growth contribution from the continued scaling of our photonics business. More on that from Carole shortly. We've delivered strong margins, high returns, and good cash conversion. This performance enabled us to reinvest at a record level — well over £600 million — in the significant opportunities we see for future growth, including a record year for both R&D spend and M&A.

Marc Ronchetti executive
#2

What you're seeing here is the payoff, accumulated over decades, from making disciplined choices and from a model that creates a virtuous growth cycle — strong performance supplies the funding for more investment in innovation, talent, and acquisitions. On this slide you'll see the main components of that sustainable growth model of ours. Back in November, when we reported half year results, I explained why this model gives me confidence in Halma's long-term prospects. What makes the model strong is that its components are interconnected and reinforce one another, so our businesses can move quickly when new opportunities appear while staying true to the group strategy of sustainable, compounding growth and returns. Essential to all of this is the outstanding talent we have throughout Halma, which serves as a crucial enabler and a performance multiplier, making sure that as we invest, adapt, and grow, value keeps compounding over the long term. In the second half of my presentation, I'll go through the main components of our ongoing investment. But first, let me pass things to Carole, who can give you more detail on how we performed financially this year.

Carole Cran executive
#3

Thank you, Marc. Good morning, everyone. A very warm welcome, and thank you for joining us this morning. I'll be taking you through the detail behind this excellent set of results. First, let's take a look at our performance against our financial targets. It's been another year of strong financial performance driven by broad-based growth, strong returns, and healthy levels of cash generation. Throughout the presentation, I'll focus on the numbers excluding the small one-off from the Navtech transaction that we completed in the first half of the year. First, we have delivered very strong revenue and profit growth, well ahead of our targets. Organic revenue up 16%, well above our 5% target, even excluding the premium photonics growth. With EBIT growing an impressive 19%, resulting in an exceptionally strong EBIT margin of 22.7%, up 110 basis points, towards the upper end of our target range. This means we've delivered EPS growth of 21%, far exceeding our KPI target of 10%. Our strong growth and returns enabled us to continue to invest for the long term, with our companies investing 123 million in R&D, representing 4.7% of group revenue. Fantastic to see our M&A momentum driving acquisition profit growth of 8.3%, above our KPI target of 5%.

Carole Cran executive
#4

Cash conversion also came in at 93%, which beat the 90% KPI target we set. That shows solid cash management and working capital discipline throughout the group. And last, with profit growth as strong as it was, ROTIC reached 16.2%, an increase of 120 basis points. Let's turn now to revenue growth and dig into the details. This slide walks from the 14.4% reported year-on-year revenue growth. Organic revenue growth was very strong, at 16.2%. That was spread fairly broadly across all three sectors, with volume driving most of the growth and price increases at a typical 1 to 2%. On top of that, organic revenue got a boost from the premium in our photonics business, which made up roughly half of that growth. Acquisitions — Lamidey Noury, Brownline, ETS, and Safetech — added 2.5% to growth. Currency was a 2.8% headwind, mainly from the US dollar weakening against sterling. Let's move on now to profit and margin growth. Adjusted EBIT rose 20.3%, and a particularly strong 19% on an organic basis. That outpaced revenue growth, reflecting the strength of the top line, focused operational delivery, targeted product and portfolio management, and good overhead control, all combined with continued investment across our companies. Acquisitions added 3.9% of profit, again ahead of their revenue contribution, which reflects the quality of the businesses we've acquired.

Carole Cran executive
#5

Disposals added a modest amount to margins as well. The currency headwind was comparable to revenue's, at 2.8%. Now turning to the sector commentary. We'll begin with Safety, where it's encouraging to see additional positive momentum after 2 years of double-digit profit growth. This broad-based performance rested on growth in all four of Safety's subsectors. Revenue rose 6.5% on an organic constant currency basis. Healthy customer demand levels supported strong momentum in public safety, along with good growth in fire and worker safety. Continued rollout of new products across the sector gave growth further support. Adjusted profit was up 16%, or 13% on an organic basis, marking our third consecutive year of double-digit organic profit growth. Profit margin rose 260 basis points, reaching 26.8%. That's a historic high for the sector, driven by continued strong revenue growth, companies optimizing their product and portfolio mix, good cost control, and the benefits of active portfolio management. It's encouraging to see our Safety companies keep making substantial investments, investing ahead of revenue growth. R&D spend rose 12% to 56 million, equal to 6% of sector revenue, reflecting the significant opportunities they've identified for delivering future growth.

Carole Cran executive
#6

M&A has been busy this year in Safety as well, with two excellent businesses brought on board during the period. Those were ETS, which stands as our biggest acquisition so far, at 226 million, along with Safetech, at 64 million. Between them, they widen the fire safety portfolio we offer and reinforce where we stand in industrial markets. Moving now to Environmental & Analysis. This slide presents E&A's results with the Navtech one-off excluded. A slide in the appendix lays out the figures with that benefit included. Very strong organic revenue growth of 34.4% was delivered by the E&A sector. It's encouraging to see double-digit growth in all three subsectors, and photonics inside optical solutions stands out as particularly strong, something I'll come back to shortly. Within environmental monitoring and measurement, demand in the US and Asia for gas detection and management solutions drove growth. In water analysis and treatment, growth was helped by robust demand for water infrastructure products and solutions across the US and UK. Profit rose 30% to 241 million, with an increase of a similar size on an organic basis. That reflected a profit margin 40 basis points lower, at 23.5%, driven by mix. As with Safety, it's great to see the substantial opportunities ahead mirrored in a healthy lift in R&D investment, up 23% to 35 million.

Carole Cran executive
#7

Like I mentioned at the half year mark, this represents a reduced level of spending measured against sector revenue in comparison with the other sectors — 3.4% — which mirrors the premium growth in photonics, since R&D forms part of the revenue we generate there. It's also good to see a robust 4.3% profit contribution coming from acquisitions, among them Brownline and Mini-Cam's bolt-on, Hathorn. I'd like to take a moment now to discuss photonics premium growth and give a bit more color on the work we do for this customer. To recap, we bought Avantes Photonics in 2011 — a business showing many hallmarks typical of a high-quality Halma company. That company's outstanding capacity to spot and seize growth opportunities has grown into a relationship spanning over a decade with a large hyperscaler technology customer. Although the relationship stays commercially confidential, we can say a little more about its nature. It features close technical collaboration, in which our customer's IP is applied together with our own expertise in co-designing and manufacturing optical switches. We have worked alongside the customer across multiple generations of the technology for more than a decade. In FY '26, premium growth contributed roughly 8 percentage points to the group's organic revenue growth, producing a photonics growth rate of 52%.

Carole Cran executive
#8

What that means is this customer is now responsible for 20% of group revenue. It's a remarkable success story, and it speaks to how strong the local management team is at delivering at scale, with the Halma model supporting them. Going forward, trends in this market are clearly dynamic, and in fast-growing markets there will always be technology choices, plus the pace of development and rates of growth will be shaped by various supply-side constraints across the data centre market. Given a combination of strong customer demand and our continued scaling, we currently expect premium growth of approximately 5 percentage points of group in FY '27, implying a growth rate of a further 30%. That builds on the exceptional growth already achieved, with revenue having more than doubled over the past 2 years, as the local management team have successfully and rapidly scaled the business. Now let's move on to our final sector, Healthcare. It's pleasing to see the continued recovery in Healthcare, with revenue up 6.3% on an organic basis and profit up 10%, with good levels of growth across all three subsectors. This reflected good execution against a background of broad-based recovery in healthcare end markets, supported by improving customer confidence and demand for products and solutions to help facilitate patient diagnosis and treatment, and greater efficiency for healthcare providers.

Carole Cran executive
#9

As you'll see in these results, we've reorganized the companies in our Healthcare sector into three new subsectors that better mirror the patient journey. Discovery, Prevention & Diagnostics put in a strong showing, helped by solid demand in vital signs monitoring and eye health diagnostics. Organic revenue growth was broad-based in therapeutic solutions, with robust demand for our respiratory device and surgical instrument products. Results in Healthcare Enablement came from demand for solutions that make healthcare delivery more efficient. Sector profit rose 10%, and the margin came in 100 basis points higher at 23.9%, thanks to stronger revenue growth, ongoing discipline on pricing and product mix, and solid overhead control. Like our other two sectors, the Healthcare companies are well invested, with R&D at 5.2% of revenue, which shows their confidence in the growth opportunities in their end markets. Acquisitions also added a healthy 2.3% to profit, reflecting the quality of the businesses we've bought. Next I'll cover our cash flows and balance sheet, and how we're investing for future growth. Because our companies generate cash, we could invest well over 600 million during the year to support future growth while keeping a strong financial position.

Carole Cran executive
#10

Cash management and working capital control stayed solid across the group, with working capital coming in at 18% of revenue, which sits within our typical range. Organic investment ranks first among our capital allocation priorities, since it underpins long-term growth — here that shows up as 179 million spent through R&D and capex. Alongside solid underlying working capital management, that produced cash conversion of 93%. Continued value-enhancing acquisitions come second on that list. During this year we put a record 475 million into acquisitions. Third is a progressive return to shareholders via the dividend, with 90 million returned — marking our 47th consecutive year of dividend growth of 5% or more. Lastly, leverage stands at just over 1x net debt to EBITDA, which mirrors the acquisitions completed during the year and remains comfortably inside our operating range of up to 2x. Let me turn to my final slide, covering our guidance for this year. We have started the 2027 financial year positively. Although the economic and geopolitical backdrop is still uncertain, and conditions in our companies' end markets continue to vary, we anticipate delivering low double-digit percentage organic constant currency revenue growth. That figure includes roughly 5 percentage points of expected premium growth from our photonics business.

Carole Cran executive
#11

We expect the adjusted EBIT margin to be consistent with FY '26, leaving out the one-off related to Navtech. At this point, I'll turn things back over to Marc.

Marc Ronchetti executive
#12

Thanks, Carole. It's truly great to witness this outstanding performance, which is hitting every one of our financial targets. In this part, as I noted before, I'd like to give you some perspective on the way we approach continuous, sustainable investment and explain why that matters so much for growth over the long term. Through our sustainable growth model, we're able to put money into future growth while preserving our organizational agility and our entrepreneurial culture. That lets us continue scaling the model while holding on to the essential pieces of our DNA. As I've said before, we're putting this stretch of premium growth from our photonics business to work in that same manner, investing further in the opportunities we see lying ahead, so that we keep expanding sustainably for decades to come. Before walking you through these investment areas, allow me to frame them against our long-term track record. If you look at the track record shown on the slide, we have compounded revenue and profit at a double-digit growth rate across the last 20 years — revenue at 11% annually and profit at 12%. That speaks to the quality and consistency of execution throughout our companies, with each one focused on delivering its own strategy within attractive niches and supported by long-term growth drivers. In recent years, our photonics business has given that growth a tailwind.

Marc Ronchetti executive
#13

Even so, had we removed its contribution completely, we would still have compounded at a double-digit rate across this period. Our decentralized model lets us capture the fullest opportunity with our hyperscaler customer while staying true to our group strategy of sustainable, compounding growth and returns over the long term. Crucially, our model makes sure this premium growth, achieved via local execution, does not pull focus from our other portfolio companies and management teams. They stay entirely focused on their own growth strategies, including continued sustainable investment for future growth. The broad-based growth we described in today's results is a great illustration of this in action. Going forward, as we work to maximize the photonics opportunity ahead of us, we do so knowing that its growth profile differs from the wider group's in pace, scale, and longevity, and may mean growth at the group level is more front-end loaded. To be clear, our growth ambition is as strong as ever. Even from our now much higher base, our aim is to keep up our track record of compounding at a double-digit rate over the long term. As I've said, we're using this period of premium growth to do exactly that, reinvesting the premium cash flows to further strengthen the wider group, as I'll now walk you through.

Marc Ronchetti executive
#14

Carole has already told you about how we kept investing heavily throughout the year. Let me lay this out across three main areas. First, our companies invest continuously in order to grow. Second, we put money into talent, our network, and new capabilities so that our companies can grow more quickly. Third, we buy purpose-aligned companies with a long-term view and manage our portfolio actively. Now let me give a bit more detail on these key investment areas. First, as Carole mentioned, our top capital allocation priority is putting capital into organic growth. By the time they join the group, our companies are already great businesses. Our job is to back their growth and their continued capacity to scale over the long term. One key driver of that is our companies' ongoing spending on R&D and innovation. We put 123 million into R&D this year, which keeps our businesses differentiated, relevant, and well positioned within their niches in attractive long-term markets. Importantly, R&D is bottom-up — driven by our companies, which sit close to their customers and markets, and aligned with each one's own growth strategy, rather than mandated from the center. In the end, these investments show the confidence our leaders have in the opportunities they see in their markets, and our commitment to backing their long-term growth.

Marc Ronchetti executive
#15

I'll illustrate this with a few illustrations spanning three areas: new market access, new product development, and incremental R&D. On new market access: SunTech leads in clinical-grade blood pressure monitoring that tolerates motion. The company has taken that expertise into animal care, carrying its core capabilities into a neighboring market that is growing faster — a superb demonstration of outstanding agility in seizing a growth opportunity for a period of time, while staying focused on long-term delivery in core markets. On new product development: BEA used its know-how in automatic door sensors to create the EvoLoop product for automatic car barriers. It takes the place of induction loops, boosting efficiency and cutting installation time, and it adds to organic growth in its core markets. On incremental R&D: Crowcon has upgraded its gas detection IQ range by evolving an established product platform, expanding capability and customer value in its existing markets. The range makes gas detection simpler through modular technology, fast servicing, and smart connected insights, all without compromising safety or protection. Those are just three examples of how our companies keep investing for long-term growth. Turning to the second area of investment, talent. Talent matters in any business, but in a decentralized group like ours, it is vital. Our decentralized structure depends on us continuing to attract, develop, and retain entrepreneurial leaders who can grow each business as if it were their own.

Marc Ronchetti executive
#16

Our approach to cultivating leaders is purposeful and built for the long term — we blend internal development with external recruitment so that, over time, we create teams that are diverse, resilient, and high-performing. Beyond that, we're making intentional investments to build a pipeline of leaders across the group, which gives us both agility and resilience. Over the year, 20 leaders were promoted onto company boards. Nearly 300 leaders took part in our development programs. Every one of our most recent sector and divisional chief executive appointments came from internal promotions. We're doubling our Catalyst graduate program and broadening our rotational placements so they focus on AI within our tech team — a strong example of strengthening our capabilities while developing the next generation of AI business leaders. We're also investing ahead of need in talent platforms and tools that help our companies develop their own people, and we're reinforcing accountability for talent and culture at a local level so we maintain our agility. We've put further investment into our network. Our annual Accelerate senior leadership conference took place in April, and we've facilitated a number of in-person conferences for many of our functional networks, including finance, talent, supply chain, and digital. Through these events, leaders can connect, share experience, and access expertise across Halma, which helps them solve problems faster, spot opportunities earlier, and scale proven ideas more effectively.

Marc Ronchetti executive
#17

When the group expands, our network's worth rises, and it is turning into a more and more significant competitive advantage source. Don't simply believe me. Let's listen to how strong the network is from a few of our leaders at the latest Accelerate conference. The Halma network has been superb nearly from the very first day I joined. I entered a rather difficult set of circumstances, and a team over in Asia was extremely supportive in helping us work through something. Then, more recently, we now wish to make certain modifications in the business, and people have approached us saying, "Here are some ideas. Here is a template. Come and visit us. Look at what we've accomplished and see what we can achieve together." I'm fortunate enough to be on my third Halma organization, and across that journey, I've been with Halma for nearly 14 years now. I've developed a fairly solid network. Each time I encounter a specific challenge, I rely on my network constantly. Whether that involves examining organizational structures and changes I'm intending to make, someone elsewhere in the Halma organization will have already done that, and there will be excellent lessons to share with me. At CenTrak, the Halma network has assisted us, and even me personally, via thought partnership.

Marc Ronchetti executive
#18

Some market analysis work done by other groups has come my way, and being able to review it deepened my grasp of various markets I hadn't really known much about. All of that came about purely through networking. I wasn't digging into research or pulling anecdotal details from AI. These were individuals who had spent years in the market and in the field, and they gave me their knowledge at no cost, just in a quick conversation. You wind up meeting all sorts of new and different people. It's simply remarkable that a connection exists with them, regardless of which part of the world they come from, what languages they speak, or what their native language is. You just think, "Wow, this is great." There's something new I can learn from them. What I'd say is the greatest strength of the Halma network is really the diversity that exists within what we've got in our business. Whatever problem you've got, there's someone inside the business you can turn to. It's very rare that you have to go outside the business to actually find a resolution. It's like having phone a friend on hand. The biggest thing for me at Halma is, yes, we're companies that we're all competing for that growth award and bits and pieces, but it's not the competition.

Marc Ronchetti executive
#19

What stands out is that curiosity whenever we're in those discussions. I think what emerges each time you attend these events is the curiosity about that competition. It's incredibly powerful, and people truly have a desire to learn. They're eager to pose thoughtful questions. They want to bring that knowledge back into their own businesses. There are perhaps a few ways in which I've attempted to contribute back to the Halma network. For sure, I'm aware that plenty of the companies have gone through rebranding efforts involving various bolt-ons and the combining of different Halma organizations. That's something we carried out in the early days at Avire?, and we didn't get it right in every respect, but I certainly hope that sharing some of those lessons has benefited others. There were some excellent remarks from our leaders: Kate spoke about the network sharing ideas and templates so we can see what's possible together; Fay mentioned applying her experience gained at another Halma company; Marcus discussed experts sharing their own market analysis work; and Joe highlighted the strength of connections and how all of us, as leaders, pick up something new. These are just a handful of great illustrations of how much collaboration and talent matter at every level of our business, and it's always such a fantastic and energizing event.

Marc Ronchetti executive
#20

We've also put more into our M&A capabilities by bringing in a modest number of people for our sector M&A teams and our central functions that support acquisitions and disposals, and by appointing two new divisional chief executive roles. These investments boost our capacity and resources to engage and build relationships with potential acquisitions, and they support the execution of a large number of transactions. With this added capacity, we keep taking a disciplined, long-term approach to managing our portfolio. As Carole highlighted, an excellent year for M&A, with record investment in acquisitions. Great to see a well-balanced mix of both acquisition sizes and types, including standalone and bolt-on transactions across all three sectors. Also positive to see the momentum continue since the year-end, with two further bolt-ons completed for 75 million. Alongside this, we continue to actively manage our portfolio. Our intent is to buy a business to own for decades, and when reviewing our portfolio, our approach starts with a simple question: Would I buy this business today? As a result, we completed three disposals in the last 12 months: AAI in Safety, Labsphere in E&A, and Cardios in Healthcare. Having found great new homes for these companies, it allows us to redeploy capital into the opportunities where we see the strongest long-term potential.

Marc Ronchetti executive
#21

When it comes to acquisitions, we begin by charting the markets that interest us and pinpointing niches backed by long-term growth drivers — which includes forming a view on emerging and accelerating megatrends. Generally, we buy businesses that sit adjacent to, or within, markets we already understand well, and we stay disciplined the whole way through, never feeling pressured to complete a deal, including stepping away when that's the right call. Let me point to a few: ETS, Brownline, and MST's bolt-ons, Ultramax and Surgistar — every one a strong illustration of the business quality our approach produces. ETS extends our fire safety portfolio and bolsters our standing in industrial end markets, propelled by the need for critical infrastructure resilience and tightening regulation. Brownline rests on long-term growth drivers: urbanization, the need for resilient infrastructure including water, electrification, and the build-out of fiber networks, plus the growing use and advantages of trenchless technology. Ultramax and Surgistar, 2 bolt-ons for MST. Combined, they widen our surgical ophthalmology portfolio, extend our geographic footprint, and bring added manufacturing capability, all within a market supported by aging populations and rising demand for cataract and eye surgery. It's great to be able to welcome them into the group. The quality and pace of our M&A activity mirror the investments we've made in making our teams stronger.

Marc Ronchetti executive
#22

Acquisitions are run start to finish by our divisional chief executives, with support from our M&A teams. On top of that, bolt-on opportunities in their markets are being actively sourced and delivered by our company management teams — a reflection of the greater scale and capability now within the portfolio — and that's a key means of compounding growth while keeping local accountability in place. Going forward, we have a healthy pipeline across all three sectors, spanning both bolt-on and standalone targets, which gives us confidence in our continued ability to identify and acquire high-quality businesses that fit our criteria. To close, I wanted to bring our model to life through the voices of company founders who joined Halma at different moments across different sectors: 10 years ago, 5 years ago, and over the last 12 months. Selling to Halma was the right decision. When we weighed the other options with various acquirers, Halma stood out as the only one that truly let us stay independent, to grow as CenTrak with our brand, with the whole organization, able to draw on every kind of resource — legal, financial, sales, international, all these types of things that a smaller company kind of struggles with. To be able to focus on our technology and on our value proposition, while being able to reach out and say, "Hey, can you help me?" It makes me proud that it is still the number one company in the industry for healthcare RTLS.

Marc Ronchetti executive
#23

It's not easy. Being part of Halma has without a doubt let Ramtech spread its wings a bit more, since we were already looking at growing internationally. Knowing you have the financial support of a larger group behind you, and having the confidence that comes with it, was going to matter a great deal to Ramtech's development. Customers sit at the center of all we do. We're exploring how to back customers locally — for instance, whether we open an office in the US, because that's where we have to be to serve US customers properly. Personally, I'd do the same deal again that I did. Walking around the business today, I feel very proud of the legacy that remains here. We joined the Halma group only a short time ago, yet we've already seen the advantages of operating within a network where, say, regulatory information has been shared — something that would have been extremely hard to accomplish as a standalone company. The long-term hope is that E2S keeps growing more quickly than it would have if it had stayed independent, and that we reach markets we could never possibly have accessed.

Marc Ronchetti executive
#24

We're going to see those bolt-on acquisitions, hopefully, as companies become part of the Halma group — and that takes us into new products and new markets, and keeps growing the company for many years ahead. Some truly powerful reflections that tie those themes together: investment, the advantages of the network, and the reasons great companies decide to join Halma. You heard from Ari at CenTrak about staying independent while benefiting from the broader strength of the group. From Andy at Ramtech and Brett at E2S, who shared how that backing gives them the confidence and the capability to grow more quickly, expand internationally, and develop over the long term. These businesses all came into Halma at different moments across the last decade, yet what holds true in every story is that they have retained their autonomy and their culture, with clear accountability for growth, and they have gained the support, the capabilities, and a long-term home that helps them go further, faster. To pull it all together, today you've heard how we think about continuous, sustainable investment across three areas. First, how our companies invest in order to grow, so they stay differentiated and well positioned in attractive long-term markets. Second, how we invest in our talent, our network, and our capabilities to help our companies grow faster, and to make sure we can scale while keeping our culture and our agility.

Marc Ronchetti executive
#25

And lastly, the way we bring purpose-aligned companies into the fold for the long haul and actively oversee our portfolio. All of these are essential investment areas so that we keep delivering compounding growth over the long term. Carol has covered how strong our performance was in 2026, yet another record year achieved amid shifting market conditions. That result speaks to the strength of our sustainable growth model and to our ongoing investment in the areas that matter most. Fundamentally, our model comes to life through the exceptional talent throughout Halma, people who are accountable for long-term performance and empowered to move with agility and seize near-term opportunities — a model that fuels a virtuous cycle of growth, in which strong performance funds continuous, sustainable investment in innovation, talent, and capabilities, along with purpose-aligned acquisitions. Although we stay mindful of the wider macroeconomic and geopolitical backdrop, the strength of our model gives me confidence in our capacity to keep delivering compounding growth and returns for decades to come. That brings the presentation to a close, and we now have time for some questions. As always, you have two ways to ask questions. You can raise your hand with the tool at the bottom of the screen, and I will invite you to ask your question verbally, or you can type the question, which Carole and I will read out and then answer.

Marc Ronchetti executive
#26

Max, we'll start with you for the opening question. Thanks, and good morning. The first thing I'd like to ask about is simply the margin performance. Clearly, a superb step-up this year in Safety and Healthcare margins. Could you perhaps take us through what you believe the main successes have been when it comes to driving those margins higher? Safety has just kept climbing. I suppose, as we think about margins going forward in those two divisions, do you really see them at this point firing on all cylinders? Or, when you look at the sub-businesses inside them, which of the divisions, and perhaps where would you see room for additional margin improvement within those two divisions? Thank you.

Carole Cran executive
#27

Okay. Good morning, Max. This is Carole. Thank you for asking. We're genuinely happy with how margins look on the whole. Once more, the teams — every one of the businesses, every sector — have performed superbly. Credit to them for all the effort. On the details, Safety, since this marks the third year now of profit growth in double digits. Quite remarkable. As you pointed out, margins are at all-time peaks. My view is the clearest way to frame it is this: what the team has achieved, in a quite disciplined and focused manner across recent years, is hunting for openings throughout the entire P&L. Be it focused pushes on pricing, new product development — which you heard Marc describe in the presentation — plus some good acquisitions, bolt-ons among them, and then going through the P&L and spotting where the opportunities lie. My take on Safety margins today is that we've brought them to a solid position, with a great deal of effort behind it. Don't take it for granted that they will keep climbing beyond this point. Because clearly, the aim is to generate growth that lasts over the long term and is sustainable. That calls for investment, which you've plainly heard about this morning. I'd suggest you model margins near where they currently sit, with the standard caveat of a plus or minus to account for mix.

Carole Cran executive
#28

On healthcare, that market has been recovering from the overstocking situation it was in. Steve and the team have really delivered over the past year especially. There may be a bit more upside in those margins compared with where we finished in FY '26. Once again, clearly we're also watching the reinvestment side. Moving to E&A, that's in a good spot, down slightly year over year, and that comes down to mix. I'd suggest you model a roughly comparable level year over year. Overall, that's why guidance points to margins similar in FY '27 and FY '26. We feel we're well positioned, with a lot of effort having gone into getting there. Okay. Perhaps a quick follow-up on photonics. You've guided to 30% growth for this year. That's somewhat under the 50% you delivered last year, and I understand it's hard to give much detail. I suppose, look, a few of the questions this morning have focused on whether any design changes at the customer are behind this. You do seem to discuss co-designing with customers a great deal. Is this really about constraints at your own factory?

Carole Cran executive
#29

Is there a supply chain problem, or can you simply not make any more, so you're hitting limits? Or is some of this conservatism? Obviously we began last year with 20% growth and ended at 50. I'm just trying to get a sense—is there some conservatism in this guidance, and then how much are your own constraints, whether factory or supply chain, driving that deceleration? Thanks, Max. As you said, it's worth reminding everyone before we get into Q&A on photonics that this business is still covered by a customer confidentiality agreement. It's great to have shared more detail today, which hopefully helps and addresses some of the areas raised previously. There are still limits on what we can disclose. I do realize this may be a bit frustrating and somewhat at odds with our usual openness, but it's clearly commercially important and in the interest of all parties that we respect those boundaries. Just worth reminding everyone of that point. On your specific question, I guess our approach, rightly so, is that we're guiding based on what we can see in near-term visibility over the next 6, 12 months rather than drawing any direct read-across from hyperscaler capex or other companies in the ecosystem.

Carole Cran executive
#30

It's really grounded in what we're seeing right now. Our guidance is a reflection of customer demand, and it also reflects how well the broader market can deploy across those major areas you can all read about — land, power, water — along with our own capacity to scale. But let me make this point: it isn't capacity as such, it's probably more on the resource side as we keep scaling. And on top of that, it includes our supply chains. What you're asking for here is an entire ecosystem to keep scaling in a market that's growing fast, and that's worth putting into context. We've doubled over the last 2 years. The guidance we're giving today is for a further 30% growth on top of that — a further 160 million of revenue over the next 12 months, taking us to over 500 million. That works out to a 3-year compound average growth rate of around 40%. To my mind, that is absolutely the definition of scaling at pace. This is highly complex, sophisticated precision manufacturing that demands a high level of quality. As I say, it's very much based on what we've got in front of us. It would be remiss of us to come out with guidance that didn't reflect our best view at this moment in time.

Carole Cran executive
#31

Thanks for that, Marc — I appreciate it.

Marc Ronchetti executive
#32

Thanks, Max. I'm just checking who has their hand raised. Andrey, you're next. Great. Thanks, Marc, and good morning, all. I wanted to ask about growth in a slightly wider sense. Obviously you're delivering right across the whole portfolio, and I was just wondering how you'd assess things at the moment as you go through the divisions and the companies inside them — where are we still sort of lagging, where is the cycle perhaps still a headwind or a return to growth, and where are we firing on all cylinders? So we shouldn't be expecting any improvement there. Where do you see that balance sitting for the next couple of years? Thanks, Andrey. As you say, it's absolutely fantastic to have seen that broad-based growth across the wider portfolio over the last 12 months, and here we're executing against the strategy that we laid out 2 years ago in terms of that delivery of the premium photonics growth, but at the same time not being distracted and delivering the broad-based growth. Really pleased to see that. Of course, we're reinvesting back in the opportunities that we see, and there are plenty across the entire portfolio. In terms of outlook, clearly we are operating in a volatile environment.

Marc Ronchetti executive
#33

We've said this often: we're not immune — we're just more resilient. A portfolio will always throw up challenges. While the Middle East is a small exposure for the group overall, certain of our companies carry more exposure than others. We'll see pockets in automotive, and pockets of possible secondary effects flowing from the broader problems in the Middle East. And of course there are always project-based businesses tied to infrastructure — all of that — but none of it is material. I think you ultimately have to return to the markets we've chosen and the ones we operate in. We deliberately pick markets where our focus is on long-term drivers, where what we sell is often a small yet critical component sold on value, where the cost of not doing it is extremely high — be that regulation or human life. Operating in those markets is a solid starting point. On top of that, we add the agility within our companies, which sit close to their customers and close to their markets, and so have the autonomy to decide and respond swiftly to whatever their market needs at that particular moment, along with access to the broader resources of the group.

Marc Ronchetti executive
#34

When you take all of those factors together, I would certainly never stand here and claim there are no areas of difficulty or no areas of opportunity, but looking across the whole portfolio, we have a very high level of confidence in our ability to deliver in line with our KPIs over the medium term. Great. Thank you. If I may, invariably, a question on photonics. Thank you for the additional details and also for your comment on how you guide for this business. I just wanted to sort of go back to a year ago, when you began the year indicating an expectation of, I believe, roughly 20% growth for this business. Then Q1 was, I think, immediately a little better, and then obviously it printed 60% in the first half, and that has been the sort of run rate. I just wondered how much visibility you have on this business, and does this year look different from how you had it last year in terms of that sort of visibility, customer indications, etc.? Is it a fuller guidance for this year than what proved to be the case a year ago, if that's possible? Obviously, I appreciate you are subject to NDAs, etc. I don't think past experience can ever be a perfect example of what is going to happen in the future.

Marc Ronchetti executive
#35

To get back to the fundamental point we raised earlier: this is a business that keeps scaling. The team is doing a phenomenal job scaling this business at the pace they are, with the sophistication and quality our customer requires. It's really good to see. What differed 12 months ago versus now — I suppose we had somewhat less visibility regarding our own capacity to scale. We've demonstrated that over the last 12 months, which gives us a degree of confidence to be a bit further ahead than perhaps 12 months ago. At the same time, I return to all those broader things happening across a market that is scaling at every level. If one of your supply chains can't keep up with the pace, that will affect your ability to do so. As I say, I'll return to the point: I'm giving you an outlook reflecting our best estimate at this moment in time, based on what we have in front of us. Very helpful. Thank you very much. You're welcome, Andrey. Appreciated. Let's go to Jonathan. Good morning.

Marc Ronchetti executive
#36

Yes, I actually had 3 questions. If I may, just continuing on the photonics theme. The first was really about your disclosure of the product, obviously. Obviously, you discuss optical switches. I was just wondering whether you might go a bit further on that, if you can, regarding what kind of optical switches these are. Is it an optical circuit switch, or a packet switch, or something along those lines? A little more detail on the product would be very helpful. As for my second question — I'll just go through all 3 questions at once. The second one concerned Avantes' margin. Obviously, you mention mix. Could you just discuss where Avantes' margin stands at present? I believe in the past you guided it to be roughly consistent with the E&A average. Does that remain true, or have we seen some slight decline or pullback regarding the profitability of that business? Then the third question, again, sorry, on photonics, concerned that customer relationship. Is there any risk that the customer might dual source?

Marc Ronchetti executive
#37

Can you share anything at all about how that might unfold through '27? Thanks, Jonathan. I'll take questions one and three, and then perhaps Carole can address the margin point. On your first question, unfortunately I'm going to disappoint you, because I can't go beyond what we've already disclosed. Obviously, we've said more than we have in the past regarding multiple generations of an optical switch, but that's the limit of what I can say at that level of disclosure. On the third point, regarding the customer relationship, let me return to the fact that we've now been working with this customer for over 10 years, and throughout that period we've co-developed and manufactured the optical switches using their IP across multiple generations. From that, you can infer — and as we've said before — that there are many different activities we undertake with the customer involving stock management, manufacturing, and that co-development and R&D. The relationship there is very close. I'd point to the fact that being able to disclose more again reflects, to some degree, just how strong that relationship with the customer is.

Marc Ronchetti executive
#38

Carol, go ahead.

Carole Cran executive
#39

Sure. Hi, Jonathan. What I’d say is that it aligns with the group margin. We’ve talked about E&A before, but at that point it gets a little circular, considering the percentage it represents of E&A. It’s simpler to just refer to it at the group level. Along the same lines, it’s neither accretive nor dilutive. So there’s nothing to flag beyond something we’ve likely mentioned previously, which is that our revenue is earned through different buckets. There’s the R&D component, which Marc clearly referenced, and we also handle inventory for the wider supply chain, and then obviously manufacturing as well. In any given year, depending on that mix, the margin might differ slightly, but there’s nothing to note. Very clear. Thank you very much, both. Much appreciated.

Marc Ronchetti executive
#40

Thanks, Jonathan. Stefan, I can see you've submitted a few questions. The first one, I believe we've already addressed — how conservative is your photonics guidance? I think we covered that earlier. "Last one, I promise. Please talk us through the capacities that you have at Avantes Photonics, particularly since it seems you've moved into a new, larger facility." Again, I think I covered that with the comment that capacity isn't one of our challenges at this moment in time in the near future. Then your third question is, "Please explain the rationale for divesting Labsphere and Cardios. You cleaned up your portfolio quite a bit in the past 2 years, AAI divestment in FY '26. Are there more divestments that we should expect or have you finalized your portfolio pruning?" I guess just picking up on that one, we're always reviewing the portfolio. As I said in the presentation, every business that we buy is with the intent to keep for decades, but at the same time, it's absolutely appropriate to continue to review the portfolio, and we start with that simple question of would I buy this business today. I guess picking up specifically on Labsphere and Cardios, both of those have been a valued part of Halma over the years and been positive contributors to the group.

Marc Ronchetti executive
#41

That review made clear that the best future growth prospects for both of them lie in markets Halma isn't focused on — be that in terms of geography, the kind of spend, or the kind of market. The whole point was to find them a better home where they can deliver on their own growth strategies. That's all there is to it. On how many we're doing and how many you should expect, I think the reality is that over the years there used to be an opportunity cost attached to looking at divestments, because we had fewer resources and fewer divisional chief execs, so if you were putting effort into divesting often-growing businesses that just happened not to align with our growth strategy, you were distracting yourself from doing M&A. As we've scaled over the last 5 years, we now have the luxury of a single resource at the center that lets us either put more resources into integrations or, if there are divestments, have that extra support. I don't think there will be an uptick in divestments. We'll keep reviewing the way we have done, but where we see it's appropriate, then as we've demonstrated over the last couple of years, we'll find great homes for those businesses and look to redeploy the capital into Halma-like businesses going forward.

Marc Ronchetti executive
#42

I hope that covers the questions you sent in writing, Stefan. If there's anything I missed, please do send along another question. So let's return to the hands raised. Chet, we'll come to you next. Hi there. Good morning, Marc and Carole. Thanks for taking my questions. I have two, please, but I'll ask them one at a time. My first one is really just a clarification regarding the organic revenue guidance for next year. When you refer to low double digit, what kind of range do you have in mind? And then maybe the main drivers behind both the lower and the higher end of that range? Do you want to take that one?

Carole Cran executive
#43

We've clearly spelled out the photonics premium included in that figure. The way I'd suggest framing the remainder is that our organic constant currency target stands at 5%, with an ambition to grow at 7.5%. Landing somewhere inside that band would strike us as reasonable. It's also worth noting that we'd view that as applying across all three sectors. Thank you. And regarding the margin guidance for next year as well — the guidance clearly builds off a strong result this year, but I just want to grasp why no expansion is anticipated, given the low double-digit organic growth guide. Thank you. Sure, I'll handle that one as well. It ties back to a question raised earlier and to the reinvestment theme running through the entire presentation — that balance of ensuring we invest for the long-term growth we intend to deliver. Margins, as you noted, are already very strong. Pushing them higher isn't our aim; instead we want to keep up that reinvestment so we can hold them at that level. At any moment in any particular year, there will also be some mix effect.

Carole Cran executive
#44

That is what the guidance is built on. Thanks.

Marc Ronchetti executive
#45

Thanks, Chet. We'll move next to Christian. Good morning, Marc. Good morning, Carole. I recognize that commercial sensitivities naturally restrict how much detail can be shared regarding the technology specifics in photonics, and I won't push on that. Your forecast calls for 30% growth. I heard your earlier response to Max's question — that the guidance rests on order visibility and possibly builds in some potential supply chain challenges. Marc, you yourself noted that 30% growth could look modest next to hyperscaler capex plans for the coming 12 months, which by our calculations fall somewhere between 49% and 77%. Really, I just have two questions. First, is there a phasing dynamic worth considering — the lag between capex devoted to greenfield data center deployments and the point at which you see sales into the rack? Second, and again, no need to address tech specifics, would you agree that photonics applications amount to a penetration growth opportunity across the data center more broadly? Thanks, Christian. On phasing, I'd say we're a small yet critical component here. I think it's fairly risky to simply grab headline capex figures and attempt to map them straight back. It's much better for us to engage with and talk to our individual company that sits close to the customer, and to have those conversations — that's why it serves as the baseline for our guidance.

Marc Ronchetti executive
#46

Like I said, demand from customers is still robust, and the way I'd frame it is this: the guidance mirrors that demand, our capacity to grow, and beyond that, how quickly the wider system is able to roll out and take in new technology and broader technology. I don't believe it's my place to try to weigh in on how our spending relates to the larger capex figures being discussed. On photonics as a technology, 100%. When you consider optics, when you consider the requirements and the needs — that need for speed, latency, and efficiency — optics can undoubtedly have a part to play there, and that's fairly well documented publicly. I suppose the counterpoint to guard against is that this market is quite dynamic. Technology shifts a great deal. Investment is substantial. Customers have many choices to make. On one hand, I'd see it as an opportunity from an optical standpoint, 100%, but on the other hand, you have to recognize how dynamic the market is right now. Thanks, Marc. Perhaps I can squeeze in a follow-up, and it isn't about photonics.

Marc Ronchetti executive
#47

If we look at E&A excluding photonics and also leaving out what Navtech added, organic growth was 34%, which comes to 260 million in incremental revenue. You mentioned photonics grew a little more than 50%, with 175 million of that 267. That leaves 92 million in incremental sales, so I calculate 21% organic for the remainder of E&A, again excluding photonics and Navtech. I realize demand is strong in gas detection and water analysis, but could you give us more detail on what is actually fueling that demand? Since it is clearly far above the high single digit you would typically expect.

Carole Cran executive
#48

Okay, thanks, Christian. This is Carole. David, I believe this also answers the question you raised that’s visible on the screen, and thanks for bringing it up. Christian, your take is correct that organic growth came in at a double-digit rate, and congratulations to Constance and the team on an excellent performance. As we noted at the half-year mark, when it was also strong, there is somewhat more of a project orientation or emphasis in the E&A sector, simply because of the kind of work those companies perform. That said, it was distributed very evenly across every one of the companies. Some of the businesses in there that had softer comparatives saw a bit of a rebound, so it’s worth keeping that in mind. It was spread across the whole patch, including, in fact, some of our more recent acquisitions from the last few years. Looking ahead, returning to one of the questions asked earlier, we would not provide guidance at those levels on a forward-looking basis. We would be closer to the 5 to 7.5% range I mentioned earlier, though that should not detract from the outstanding work those companies delivered within the sector last year. Thank you both.

Marc Ronchetti executive
#49

Thank you, Christian. Rory, you're next in the queue. Please unmute. Hello, good morning. Is my audio coming through? We hear you fine, Rory. Good morning. Great, thanks so much. This is Rory calling from OxCAP. Appreciate you taking my question. I believe there's still one remaining on photonics. You've described the various components of Avantes Photonics revenue generation as being, roughly, contract R&D, inventory management services, and then the manufacturing of the optical switches themselves. When I look at the revenue recognition note, within E&A, over 50% of that revenue is now recognized over time rather than at a point in time. That's risen from 41% last year. Thinking back a few years, it was perhaps closer to the group average, maybe a bit above the other sectors, but not really at that level, right, not to the point where there's a lot of project-based revenue going on here. Certainly, much of the growth has landed in that bucket, right, in terms of revenue recognized over time. So just trying to reconcile that with your remarks, Marc, that capacity isn't your issue in the near future. Is there anything you can share with us this morning regarding how those three pieces within Avantes Photonics might shift over time?

Marc Ronchetti executive
#50

When we consider the longer-term or medium-term picture for demand on these products — or what we believe these products are accomplishing and where they're headed within the data center — then perhaps the question concerns your medium-term capacity, since the R&D side and the inventory management side decline somewhat, while component manufacturing emerges over the following 1, 2, or maybe 3 years. Am I making no sense at all here, or could you offer us any assistance on that topic? Thank you.

Carole Cran executive
#51

Rory, I'll start with the technical side of things. Hello, hi, and thank you for the question. Sorry if this makes me sound like a bit of a technical geek, but what we're dealing with here is the vagaries of IFRS 15. You're right to point to the increase, and of course, as Avo has grown over the years, so have those revenues earned over time. It really comes down to how the contract is constructed, Rory. This actually applies to each of the aspects of the revenue buckets that we earn. Although I mentioned a bit of mix effect, don't think of that as materially different over years. Then the other piece to note is that with our most recent E&A acquisition, Brownline, given its nature of providing a service rather than selling products, again, the accounting standards mean those revenues fall into that bucket. I suppose as far as how much R&D, how much inventory management, and how much manufacturing in any given year, the inventory would tend to move in fairly lockstep with the manufacturing, with maybe a little bit of plus or minus depending on inventory being bought ahead, and then the R&D, again, might move a bit, but it's not a material difference in the mix year-on-year.

Carole Cran executive
#52

I’m not sure whether there’s anything beyond those technical points that you’d like to explore further, Rory, but I hope that adds a little more context. That’s genuinely useful—thank you. I suppose also, for the market watching this today and thinking, “Well, if you were part of earlier generations, there’s a strong likelihood you’ll be part of later ones, and some of that carries the R&D spending with it, and eventually the manufacturing, too.” Clearly, the new Avo site could prove useful at some point soon. That’s excellent. Thanks so much.

Marc Ronchetti executive
#53

I suppose the one thing to add, Rory, since you brought up the near future and timelines, is that our definitions may not match. Keep in mind that here at Halma, we generally think in decades. So my near short term is likely the coming 12, 18, 24, 36 months, while in your world, I suspect that's the next quarter, and long term means 12 to 24 months. We simply have to watch out a little, with us thinking in decades and perhaps you thinking quarterly, and in how you frame timelines going forward. Absolutely. Thank you very much. Fantastic. Thank you, Rory. It seems there are no written questions. Oh yeah, one hand has gone up. Is that Ashwin? Is that right, yeah? Hi, good morning. Thank you for taking my question. Just one on data centers, but trying to focus on the other areas ex-photonics, just to ask whether you've managed to get any products into the data center market outside of the photonics, especially when we look at your Safety business. I think you have good commercial exposure over there. Can you please give clarity on that part?

Marc Ronchetti executive
#54

Absolutely. Yeah, that's a really good question. Like you mentioned, it really comes down to the fundamentals of how our businesses' models work. They possess deep application expertise regarding their technology as well as their core markets. During the presentation, I mentioned that they are constantly seeking chances in other markets to take their know-how and use it to solve problems for customers. The exact same thing would apply to data centers—whether that involves gas analysis, whether it involves safety regarding access, whether it involves a whole host of areas, fire suppression, every one of those kinds of areas. That is how the companies we own operate. They are sitting there thinking, "Alright, I am in a core market that will provide me with 3, 4, perhaps 5% growth. How can I consistently locate an additional 1 or 2% growth over the medium term?" The method I will use to achieve that is expanding my addressable market, and when there are trends that are expanding, when there are markets that are expanding, they are constantly on the lookout for those chances. Regarding that R&D spend we have observed, I am certain that portions of it will involve many of our businesses aiming to capture the advantages of growth and invest in those areas.

Marc Ronchetti executive
#55

It's definitely not a major piece of the group, and that's appropriate—it's something each of our businesses will examine from a commercial standpoint, asking whether our deep expertise can be brought to bear on spending at this level and on what gets built out across the coming X years. Thank you very much. Excellent. I don't see any more hands raised. I believe David's written question has been addressed. I suppose I'll offer a thank you on my own behalf. From where we sit, it's wonderful to have reported record results, with broad-based growth in all three sectors, record investment levels spanning R&D and M&A, and a model whose agility and resilience have been proven across decades—all of which gives us strong confidence in what lies ahead. Thank you very much for your time, and no doubt we'll all speak soon.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Halma plc transcript - plus 132,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.

Get an API key View API docs →

For developers and AI pipelines

Programmatic access to Halma plc earnings transcripts and 132,000+ others is available through the EarningsAPI REST API and the hosted MCP server. Quarterly plans from $162 - full transcripts, speaker segments, full-text search, and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.